maprotiline has been researched along with nomifensine in 37 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 25 (67.57) | 18.7374 |
1990's | 3 (8.11) | 18.2507 |
2000's | 3 (8.11) | 29.6817 |
2010's | 6 (16.22) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
Ekins, S; Williams, AJ; Xu, JJ | 1 |
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Jones, LH; Nadanaciva, S; Rana, P; Will, Y | 1 |
Anlezark, G; Meldrum, BS; Trimble, MR | 1 |
Campbell, IC; Ellison, DW | 1 |
Maletta, GJ | 1 |
Ostrow, D | 1 |
Brown, TM; Evans, DL; Golden, RN; Miller, H | 1 |
Hayes, PE; Kristoff, CA | 1 |
Gelbtuch, MH; Harris, JP; Phillipson, OT | 1 |
Calvert, JE; Gelbtuch, MH; Harris, JP; Phillipson, OT | 1 |
Blansjaar, BA; Dijken, WA; Haffmans, J; Kamp, JS; Kramer, HJ; Nolen, WA; van de Putte, JJ | 1 |
Seppälä, T; Strömberg, C; Suokas, A | 1 |
Faltus, F; Filip, V; Karen, P; Kolomazník, M; Korínková, V; Libiger, J; Molcan, J; Zapletálek, M; Zizka, V | 1 |
O'Connolly, M; Siegfried, K | 1 |
Adams, C; Gastpar, M; Kielholz, P; Terzani, S | 1 |
Ballinger, BR; Feely, J | 1 |
Golden, RN; Potter, WZ; Rudorfer, MV | 1 |
Montgomery, SA | 1 |
Desager, JP; Harvengt, C | 1 |
Balon, R; Dostal, T; Kabes, J; Papezová, H | 1 |
Levin, A | 1 |
Devoize, JL; Eschalier, A; Pechadre, JC; Rigal, F | 1 |
King, DJ | 1 |
Hollister, LE | 1 |
Laakmann, G | 1 |
Bergener, M; Hesse, C | 1 |
Balon, R; Dostal, T; Kabes, J | 1 |
Bech, P | 1 |
Götz, E; Meyer, DK; Mondeh, JD; Olenik, C; Uhl, A | 1 |
Egashira, T; Takayama, F; Yamanaka, Y | 1 |
Obata, T; Yamanaka, Y | 1 |
8 review(s) available for maprotiline and nomifensine
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
The new antidepressants.
Topics: Alprazolam; Amoxapine; Antidepressive Agents; Fluoxetine; Maprotiline; Nomifensine; Seizures; Trazodone | 1988 |
Adverse reactions to five new antidepressants.
Topics: Acute Kidney Injury; Amoxapine; Animals; Antidepressive Agents; Bupropion; Cardiovascular Diseases; Dopamine Antagonists; Humans; Male; Maprotiline; Nomifensine; Priapism; Propiophenones; Seizures; Trazodone | 1986 |
Second-generation antidepressants.
Topics: Alprazolam; Amoxapine; Antidepressive Agents; Benzodiazepines; Bupropion; Citalopram; Clinical Trials as Topic; Dopamine; Double-Blind Method; Humans; Maprotiline; Nomifensine; Norepinephrine; Propiophenones; Propylamines; Seizures; Serotonin; Trazodone; Zimeldine | 1984 |
Maprotiline, nomifensine, mianserin, zimelidine: a review of antidepressant efficacy in in-patients.
Topics: Antidepressive Agents; Brompheniramine; Clinical Trials as Topic; Depression; Humans; Maprotiline; Mianserin; Nomifensine; Psychiatric Status Rating Scales; Zimeldine | 1980 |
New developments in antidepressant medication--a review.
Topics: Antidepressive Agents; Flupenthixol; Humans; Maprotiline; Mianserin; Nomifensine; Structure-Activity Relationship; Viloxazine | 1980 |
'Second generation' antidepressant drugs.
Topics: Amoxapine; Antidepressive Agents; Antidepressive Agents, Tricyclic; Clomipramine; Humans; Maprotiline; Mianserin; Nomifensine; Trazodone; Viloxazine | 1981 |
Acute therapy of depression.
Topics: Antidepressive Agents; Antidepressive Agents, Tricyclic; Benzamides; Depressive Disorder; Drug Administration Schedule; Drug Therapy, Combination; Humans; Maprotiline; Meta-Analysis as Topic; Moclobemide; Monoamine Oxidase Inhibitors; Nomifensine; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index | 1993 |
9 trial(s) available for maprotiline and nomifensine
Article | Year |
---|---|
The new generation antidepressants: promising innovations or disappointments?
Topics: Alprazolam; Antidepressive Agents; Benzodiazepines; Bupropion; Citalopram; Clinical Trials as Topic; Depressive Disorder; Dopamine; Drug Evaluation; Fluoxetine; Humans; Maprotiline; Nomifensine; Norepinephrine; Propiophenones; Propylamines; Receptors, Neurotransmitter; Serotonin; Trazodone; Zimeldine | 1985 |
Effects of haloperidol and nomifensine on the visual aftereffects of tilt and movement.
Topics: Adult; Afterimage; Arousal; Eye Movements; Female; Haloperidol; Humans; Male; Maprotiline; Motion; Movement; Nomifensine; Posture; Reaction Time; Sleep Stages; Visual Acuity | 1986 |
Treatment strategy in depression. II. MAO inhibitors in depression resistant to cyclic antidepressants: two controlled crossover studies with tranylcypromine versus L-5-hydroxytryptophan and nomifensine.
Topics: 5-Hydroxytryptophan; Adult; Aged; Clinical Trials as Topic; Depressive Disorder; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Resistance; Female; Fluvoxamine; Humans; Male; Maprotiline; Middle Aged; Nomifensine; Oximes; Psychological Tests; Tranylcypromine | 1988 |
Interaction of alcohol with maprotiline or nomifensine: echocardiographic and psychometric effects.
Topics: Adolescent; Adult; Anthracenes; Double-Blind Method; Drug Interactions; Echocardiography; Ethanol; Female; Humans; Male; Maprotiline; Nomifensine; Psychomotor Performance | 1988 |
[Comparison of nomifensine, maprotiline and imipramine in a double-blind study of patients with endogenous depression].
Topics: Adult; Anthracenes; Clinical Trials as Topic; Depressive Disorder; Double-Blind Method; Female; Humans; Imipramine; Male; Maprotiline; Middle Aged; Nomifensine | 1986 |
Cognitive and psychomotor effects of different antidepressants in the treatment of old age depression.
Topics: Aged; Anthracenes; Antidepressive Agents; Clinical Trials as Topic; Cognition; Depressive Disorder; Double-Blind Method; Female; Humans; Male; Maprotiline; Mianserin; Nomifensine; Psychomotor Performance; Random Allocation | 1986 |
Second-generation antidepressants.
Topics: Alprazolam; Amoxapine; Antidepressive Agents; Benzodiazepines; Bupropion; Citalopram; Clinical Trials as Topic; Dopamine; Double-Blind Method; Humans; Maprotiline; Nomifensine; Norepinephrine; Propiophenones; Propylamines; Seizures; Serotonin; Trazodone; Zimeldine | 1984 |
Maprotiline, nomifensine, mianserin, zimelidine: a review of antidepressant efficacy in in-patients.
Topics: Antidepressive Agents; Brompheniramine; Clinical Trials as Topic; Depression; Humans; Maprotiline; Mianserin; Nomifensine; Psychiatric Status Rating Scales; Zimeldine | 1980 |
Nomifensine and maprotiline in endogenous depression: comparative efficacy and side effects.
Topics: Adolescent; Adult; Aged; Anthracenes; Clinical Trials as Topic; Depressive Disorder; Double-Blind Method; Female; Humans; Isoquinolines; Male; Maprotiline; Middle Aged; Nomifensine | 1982 |
22 other study(ies) available for maprotiline and nomifensine
Article | Year |
---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Development of a cell viability assay to assess drug metabolite structure-toxicity relationships.
Topics: Adenosine Triphosphate; Benzbromarone; Cell Line; Cell Survival; Chromans; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Humans; Pharmaceutical Preparations; Thiazolidinediones; Troglitazone | 2016 |
Effect of nomifensine on brain amines and epilepsy in photosensitive baboons.
Topics: Amines; Animals; Brain Chemistry; Clomipramine; Dose-Response Relationship, Drug; Imipramine; Isoquinolines; Maprotiline; Nomifensine; Papio; Photic Stimulation; Seizures | 1977 |
Studies on the role of alpha 2-adrenoceptors in the control of synaptosomal [3H]5-hydroxytryptamine release: effects of antidepressant drugs.
Topics: Animals; Antidepressive Agents; Benzylamines; Cerebral Cortex; Citalopram; Clonidine; Clorgyline; Desipramine; Hydroxyindoleacetic Acid; Male; Maprotiline; Nomifensine; Potassium; Propylamines; Rats; Rats, Inbred Strains; Receptors, Adrenergic, alpha; Serotonin; Synaptosomes; Yohimbine | 1986 |
Medications to modify at-home behavior of Alzheimer's patients.
Topics: Aged; Alzheimer Disease; Anti-Anxiety Agents; Antidepressive Agents; Antipsychotic Agents; Behavior; Benzodiazepines; Electroconvulsive Therapy; Humans; Lithium; Maprotiline; Middle Aged; Monoamine Oxidase Inhibitors; Nomifensine; Psychotropic Drugs; Trazodone | 1985 |
Modification of visual orientation illusions by drugs which influence dopamine and GABA neurones: differential effects on simultaneous and successive illusions.
Topics: Adolescent; Adult; Dopamine; Female; gamma-Aminobutyric Acid; Haloperidol; Humans; Illusions; Lorazepam; Male; Maprotiline; Neurons; Nomifensine; Optical Illusions; Orientation | 1986 |
[Management of treatment-resistant depression without ECT (author's transl)].
Topics: Antipsychotic Agents; Clomipramine; Depressive Disorder; Female; Humans; Male; Maprotiline; Nomifensine; Physical Therapy Modalities; Psychotherapy | 1981 |
Antidepressants.
Topics: Antidepressive Agents; Antidepressive Agents, Tricyclic; Brompheniramine; Humans; Maprotiline; Mianserin; Nomifensine; Trazodone; Viloxazine; Zimeldine | 1983 |
Relative acute cardiovascular toxicity induced by maprotiline, mianserin and nomifensine in conscious rabbits.
Topics: Animals; Anthracenes; Blood Gas Analysis; Cardiac Output; Dibenzazepines; Epinephrine; Hemodynamics; Injections, Intraperitoneal; Isoquinolines; Male; Maprotiline; Mianserin; Nomifensine; Norepinephrine; Rabbits; Renal Circulation | 1983 |
[A profile of the clinical effectiveness of second generation antidepressive agents].
Topics: Adult; Anthracenes; Depressive Disorder; Female; Humans; Isoquinolines; Male; Maprotiline; Middle Aged; Morpholines; Nomifensine; Viloxazine | 1984 |
Activities of five antidepressants in a behavioral pain test in rats.
Topics: Analgesia; Animals; Antidepressive Agents; Clomipramine; Desipramine; Electroshock; Male; Maprotiline; Nociceptors; Nomifensine; Rats; Rats, Inbred Strains; Viloxazine | 1983 |
[Effect of antidepressants on the secretion of pituitary hormones in healthy subjects, neurotic depressive patients and endogenous depressive patients (author's transl)].
Topics: Adult; Anthracenes; Clomipramine; Depressive Disorder; Desipramine; Female; Growth Hormone; Humans; Isoquinolines; Luteinizing Hormone; Male; Maprotiline; Middle Aged; Nomifensine; Pituitary Hormones, Anterior; Prolactin; Thyrotropin | 1980 |
A biological concept for diagnosis, treatment and therapy control of endogenous psychoses.
Topics: Age Factors; Aged; Antidepressive Agents; Benzodiazepines; Depression; Humans; Maprotiline; Nomifensine; Psychotic Disorders | 1980 |
Do have antidepressants of the second generation anxiolytic properties?
Topics: Adult; Anthracenes; Anxiety; Depressive Disorder; Humans; Isoquinolines; Maprotiline; Middle Aged; Morpholines; Nomifensine; Psychiatric Status Rating Scales; Viloxazine | 1981 |
Cerebral cortex injury: effect of blockers of re-uptake of catecholamines.
Topics: Animals; Catecholamines; Cerebral Cortex; Cholecystokinin; Male; Maprotiline; Neurotransmitter Uptake Inhibitors; Nomifensine; Protein Precursors; Rats; Rats, Wistar; Receptors, Adrenergic, alpha-1; RNA, Messenger; Sympathetic Nervous System | 1993 |
The inhibition of monoamine oxidase activity by various antidepressants: differences found in various mammalian species.
Topics: Animals; Antidepressive Agents; Binding, Competitive; Brain; Dogs; Imipramine; Isoenzymes; Kinetics; Macaca; Male; Maprotiline; Mice; Mitochondria; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Nomifensine; Rats; Rats, Wistar; Species Specificity; Zimeldine | 1999 |
Inhibition of monkey brain semicarbazide-sensitive amine oxidase by various antidepressants.
Topics: Adrenergic Uptake Inhibitors; Amine Oxidase (Copper-Containing); Animals; Antidepressive Agents; Brain; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Imipramine; Macaca; Male; Maprotiline; Neurons; Nomifensine; Selective Serotonin Reuptake Inhibitors; Time Factors; Zimeldine | 2000 |